3617 Results

People

  1. Levine
    Levine
  2. Scheinberg
    Scheinberg
  3. Tallman
    Tallman
  4. Rampal
    Rampal
  5. Brentjens
    Brentjens
  6. Abdel-Wahab
    Abdel-Wahab
  7. Mauro
    Mauro
  8. Park
    Park
  9. Stein
    Stein
  10. Berman
    Berman

Groups

  1. Adult Leukemia (3617)
  2. Center for Hematologic Malignancies (3617)
  3. Department of Medicine (3586)
  4. Hematologic Malignancies, Division of (3582)
  5. GSK Faculty (1754)
  6. Executive Committee, Center for Hematologic Malignancies (948)
  7. Tow Center for Developmental Oncology (TCDO) (924)
  8. Center for Molecular Imaging and Biotechnology (912)
  9. Hematologic Malignancies Research (871)
  10. Human Oncology and Pathogenesis Program (822)
  1. "Adult Leukemia"
Formats
  1. Meeting Abstract (1737)
  2. Journal Article (1573)
  3. Review (118)
  4. Research Letter (52)
  5. Editorial (46)
  6. Book Section (39)
  7. Guidelines (19)
  8. Conference Paper (18)
  9. Correspondence (12)
  10. Miscellaneous (2)
  11. Book Whole (1)
Groups
  1. Adult Leukemia (3617)
  2. Center for Hematologic Malignancies (3617)
  3. Department of Medicine (3586)
  4. Hematologic Malignancies, Division of (3582)
  5. GSK Faculty (1754)
  6. Executive Committee, Center for Hematologic Malignancies (948)

More Groups

People
  1. Ross Levine (774)
  2. Martin Tallman (649)
  3. David Scheinberg (499)
  4. Jae Park (356)
  5. Eytan Stein (341)
  6. Raajit Rampal (338)

More People

Years
  1. 2025 (51)
  2. 2024 (145)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1200)
  2. Journal of Clinical Oncology (214)
  3. Clinical Lymphoma, Myeloma and Leukemia (116)
  4. Leukemia (108)
  5. Haematologica (106)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1289)
  2. Nature Publishing Group (317)
  3. Elsevier Inc. (256)
  4. American Association for Cancer Research (232)
  5. American Society of Clinical Oncology (225)
  6. Ferrata Storti Foundation (106)

More Publishers

Results (3617)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Identifying people with acute lymphoblastic leukemia who are most suitable for treatment with inotuzumab ozogamicin: A plain language summary
    Review

    Marks, D. I.; Cassaday, R. D.; Ribera, J. M.; Schuh, A. C.; Park, J. H.; Chiaretti, S.; Stelljes, M.
    Expert Review of Hematology (2025)

    Fulltext@MSK | Save
  • Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis: A randomized phase 3 trial
    Journal Article

    Rampal, R. K.; Grosicki, S.; Chraniuk, D.; Abruzzese, E.; Bose, P.; Gerds, A. T.; Vannucchi, A. M.; Palandri, F.; Lee, S. E.; Gupta, V.; more...
    Nature Medicine (2025)

    Fulltext@MSK | Save
  • Asciminib in combination with imatinib, nilotinib, or dasatinib in patients with chronic myeloid leukemia in chronic or accelerated phase: Phase 1 study final results
    Journal Article

    Cortes, J. E.; Lang, F.; Rea, D.; Hochhaus, A.; Breccia, M.; Goh, Y. T.; Heinrich, M. C.; Hughes, T. P.; Janssen, J. J. W. M.; le Coutre, P.; more...
    Leukemia (2025)

    Fulltext@MSK | Save
  • Asciminib monotherapy in patients with chronic myeloid leukemia in chronic phase without BCR::ABL1T315I treated with at least 2 prior TKIs: Phase 1 final results: CHRONIC MYELOID LEUKEMIA
    Journal Article

    Hochhaus, A.; Kim, D. W.; Cortes, J. E.; Sasaki, K.; Mauro, M. J.; Hughes, T. P.; Breccia, M.; Talpaz, M.; Minami, H.; Goh, Y. T.; more...
    Leukemia (2025)

    Fulltext@MSK | Save
  • Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3
    Journal Article

    Shah, B. D.; Cassaday, R. D.; Park, J. H.; Houot, R.; Logan, A. C.; Boissel, N.; Leguay, T.; Bishop, M. R.; Topp, M. S.; O’Dwyer, K. M.; more...
    Leukemia (2025)

    Fulltext@MSK | Save
  • Mutant IDH1 cooperates with NPM1c or FLT3(ITD) to drive distinct myeloid diseases and molecular outcomes
    Journal Article

    Sakamoto, T.; Leca, J.; Zhang, X.; Meydan, C.; Foox, J.; Ramachandran, P.; Hendrikse, L. D.; Zhou, W.; Berger, T.; Fortin, J.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2025)

    Fulltext@MSK | Save
  • A human antibody specific for SIRPα reprograms macrophages and promotes antibody mediated anti-cancer activity
    Journal Article

    Kurtz, K. G.; Lebedeva, I.; Pierre, S. A.; Andrew, D.; Liao, Y. R.; Ambriz, D.; Vergnolle, O.; Shen, L.; Nyakatura, E.; Baca, M.; more...
    PLoS ONE (2025)

    Fulltext@MSK | Save
  • TP53 mutations and TET2 deficiency cooperate to drive leukemogenesis and establish an immunosuppressive environment
    Journal Article

    Zhang, P.; Whipp, E. C.; Skuli, S. J.; Gharghabi, M.; Saygin, C.; Sher, S. A.; Carroll, M.; Pan, X.; Eisenmann, E. D.; Lai, T. H.; more...
    Journal of Clinical Investigation (2025)

    Fulltext@MSK | Save
  • Impact of clonal hematopoiesis on solid tumor progression following radiation therapy
    Journal Article

    Tao, J. J.; Setton, J.; Vela, P. S.; Safonov, A. M.; Comen, E. A.; Braunstein, L. Z.; Reis-Filho, J. S.; Riaz, N.; Powell, S. N.; Levine, R. L.; more...
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Protein profiles predict treatment responses to the PI3K inhibitor umbralisib in patients with chronic lymphocytic leukemia
    Journal Article

    Yin, Y.; Xu, H.; He, L.; Brown, J. R.; Mato, A. R.; Aittokallio, T.; Skånland, S. S.
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save